Company Search:
Advanced Search
Sponsored Links
Hypermarcas SA Company Snapshot
Hypermarcas SA operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hypermarcas SA with three other pharmaceutical manufacturers in Latin America: Fleury SA (2016 sales of 2.10 billion Brazilian Reals [US$651.18 million] of which 83% was Diagnostic Medicine), Genomma Lab Internacional Sab De Cv of Mexico (11.32 billion Mexican Pesos [US$594.11 million] of which 59% was International), and Diagnosticos Da America SA (3.04 billion Brazilian Reals [US$944.65 million] of which 100% was servi os auxiliares).

Sales Analysis. Hypermarcas SA reported sales of 3.29 billion Brazilian Reals (US$1.02 billion) for the year ending December of 2016. This represents an increase of 11.2% versus 2015, when the company's sales were 2.96 billion Brazilian Reals. Despite this increase, sales are still well below the level achieved in 2014, when Hypermarcas SA reported sales of 4.68 billion Brazilian Reals. The sales level in 2016 was fairly close to the level five years ago: in 2011, Hypermarcas SA had sales of 3.32 billion Brazilian Reals.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Hypermarcas SA
  Stock Performance Chart for Hypermarcas SA
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 36.50
(Figures in Brazilian Reals)
1 Week 1.4%   13 Weeks 4.9%  
4 Weeks 4.7%   52 Weeks 39.9%  
Hypermarcas SA Key Data:
  Ticker: HYPE3 Country: Brazil
  Exchanges: SOP Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 3,288,747,000
(Year Ending Jan 2017).
Employees: 8,787
  Currency: Brazilian Reals Market Cap: 23,072,401,207
  Fiscal Yr Ends: December Shares Outstanding: 632,120,581
  Share Type: Ordinary Closely Held Shares: 264,871,655
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.